Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-013752
Filing Date
2019-04-29
Accepted
2019-04-29 16:34:29
Documents
4
Period of Report
2019-06-03
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A xene-def14a_20190603.htm DEF 14A 1540046
2 GRAPHIC gyifi4i542qv000003.jpg GRAPHIC 1897
3 GRAPHIC gyifi4i542qv000002.jpg GRAPHIC 6067
4 GRAPHIC gyifi4i542qv000001.jpg GRAPHIC 6067
  Complete submission text file 0001564590-19-013752.txt   1560868
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36687 | Film No.: 19776399
SIC: 2834 Pharmaceutical Preparations